SYNOPSYS INC — Director's Dealing 2020

Dec 23, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SYNOPSYS INC (SNPS)
CIK: 0000883241
Period of Report: 2020-12-22

Reporting Person: RUNKEL JOHN F JR (GC & Corporate Secretary)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-09	Common Stock	G	220	$0.0	Disposed	19377	Direct
2020-12-14	Common Stock	G	140	$0.0	Disposed	20702	Direct
2020-12-15	Common Stock	G	140	$0.0	Disposed	20562	Direct
2020-12-22	Common Stock	M	2052	$60.37	Acquired	22614	Direct
2020-12-22	Common Stock	S	2052	$257.012	Disposed	20562	Direct
2020-12-22	Common Stock	M	6288	$135.88	Acquired	26850	Direct
2020-12-22	Common Stock	S	6288	$257.012	Disposed	20562	Direct
2020-12-22	Common Stock	M	1323	$89.76	Acquired	21885	Direct
2020-12-22	Common Stock	S	1323	$257.012	Disposed	20562	Direct
2020-12-22	Common Stock	M	1343	$90.51	Acquired	21905	Direct
2020-12-22	Common Stock	S	1343	$257.012	Disposed	20562	Direct
2020-12-23	Common Stock	G	220	$0.0	Disposed	20342	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-12-22	Non-Qualified Stock Option (right to buy)	$60.37	M	2052	Disposed	2023-12-15	Common Stock (2052)	Direct
2020-12-22	Non-Qualified Stock Option (right to buy)	$89.76	M	1323	Disposed	2025-12-12	Common Stock (1323)	Direct
2020-12-22	Non-Qualified Stock Option (right to buy)	$90.51	M	1343	Disposed	2024-12-08	Common Stock (1343)	Direct
2020-12-22	Non-Qualified Stock Option (right to buy)	$135.88	M	6288	Disposed	2026-12-12	Common Stock (6288)	Direct

Footnotes

F1: Gift

F2: Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $257.00 to $257.06. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range.

F3: 1/4 of the grant becomes exercisable one year after grant date with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date.